Juan W. Valle/LinkedIn
Jul 24, 2025, 09:37
Juan Valle: The Cholangiocarcinoma Foundation Will Accept Letters of Intent for Two Major Grant Programs
Juan Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, shared on LinkedIn:
“Beginning August 1, the Cholangiocarcinoma Foundation will accept Letters of Intent for two major grant programs:
- The CCF Innovation Grant
- Career Development Award (CDA)
The 2025 Innovation Award, supported by the Mather Family Foundation, will provide $750,000 over three years for bold clinical trial designs and novel therapies to transform cholangiocarcinoma care.
The CDA offers $300,000 over three years to support mid-career investigators establishing independent research programs in cholangiocarcinoma. Letters of Intent for both opportunities are due by August 22, 2025.
Please visit here for more information and to view the requests for applications.”
More posts featuring Juan W. Valle.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 16:47
Sep 7, 2025, 16:30
Sep 7, 2025, 16:25